Pfizer Inc
NYSE:PFE
Pfizer Inc
Net Income (Common)
Pfizer Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pfizer Inc
NYSE:PFE
|
Net Income (Common)
$2.1B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-21%
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Income (Common)
$40.6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Income (Common)
$8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Merck & Co Inc
NYSE:MRK
|
Net Income (Common)
$365m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-22%
|
|
Zoetis Inc
NYSE:ZTS
|
Net Income (Common)
$2.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Income (Common)
$5.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
See Also
What is Pfizer Inc's Net Income (Common)?
Net Income (Common)
2.1B
USD
Based on the financial report for Dec 31, 2023, Pfizer Inc's Net Income (Common) amounts to 2.1B USD.
What is Pfizer Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-21%
Over the last year, the Net Income (Common) growth was -93%. The average annual Net Income (Common) growth rates for Pfizer Inc have been -40% over the past three years , -28% over the past five years , and -21% over the past ten years .